Stocksigma LogoStocksigma Logo

Par Drugs and Chemicals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)

■ Revenue: 2,743 (-4.3% YoY | -12.3% QoQ) ■ EBITDA: 450 (-25.8% YoY | -29.4% QoQ) ■ EBITDA Margin (%): 16.4 (-475 bps YoY | -398 bps QoQ) ■ PAT: 263

Par Drugs and Chemicals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)

Par Drugs and Chemicals Ltd · Outcome · 29 Oct 2026, 10:31 pm

Par Drugs and Chemicals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 2,743 (-4.3% YoY | -12.3% QoQ) ■ EBITDA: 450 (-25.8% YoY | -29.4% QoQ) ■ EBITDA Margin (%): 16.4 (-475 bps YoY | -398 bps QoQ) ■ PAT: 263 (-36.4% YoY | -44.2% QoQ) ■ EPS (INR): 2.14 (-36.3% YoY | -44.1% QoQ)

Original exchange filing (PDF)

More announcements from Par Drugs and Chemicals Ltd

All Par Drugs and Chemicals Ltd announcements